{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T05:01:32Z","timestamp":1792213292229,"version":"4.4.0"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","license":[{"start":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T00:00:00Z","timestamp":1745452800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Kidney360"],"published-print":{"date-parts":[[2025,9]]},"abstract":"\n Key Points<\/jats:title>\n \n \n \n Proactive desmopressin was associated with reduced overcorrection of hyponatremia compared with reactive\/rescue desmopressin or no desmopressin.<\/jats:p>\n <\/jats:list-item>\n \n No significant differences in adverse events were observed between proactive, reactive\/rescue, and no desmopressin strategies.<\/jats:p>\n <\/jats:list-item>\n \n Plasma sodium was checked more often in the proactive desmopressin group.<\/jats:p>\n <\/jats:list-item>\n <\/jats:list>\n <\/jats:p>\n <\/jats:sec>\n \n Background<\/jats:title>\n Coadministration of hypertonic saline (HTS) 3% and desmopressin from the outset of treatment (\u201cDDAVP clamp\u201d or proactive desmopressin) has been suggested to prevent inadvertent overcorrection of hyponatremia, but its effectiveness and safety remain uncertain.<\/jats:p>\n <\/jats:sec>\n \n Methods<\/jats:title>\n We identified adult patients hospitalized between July 1, 2018, and June 30, 2023, at four University of Pittsburgh Medical Center hospitals with a plasma sodium (PNa) \u2264120 mEq\/L at admission or during hospitalization who were treated with HTS. We compared outcomes between patients who were treated with proactive desmopressin and those who either did not receive desmopressin or received it using a reactive\/rescue strategy.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n \n A total of 184 patient admissions (57.6% female, mean age 60.6 years) met inclusion and exclusion criteria. Hyponatremia was chronic in 93.5% of patients; leading causes were syndrome of inappropriate antidiuresis (51.6%), hypovolemia (25.5%), and low solute intake (15.8%), and 20.1% had seizures. Cases treated with proactive desmopressin (\n n<\/jats:italic>\n =44) were compared with cases treated without proactive desmopressin (\n n<\/jats:italic>\n =140). Despite a lower baseline PNa (110.2\u00b16.3 versus 115.2\u00b17.2 mEq\/L,\n P<\/jats:italic>\n < 0.001), correction by >8 mEq\/L (6.8% versus 27.1%,\n P<\/jats:italic>\n = 0.009) or >10 mEq\/L (0% versus 15%,\n P<\/jats:italic>\n = 0.014) within the first 24 hours was significantly less frequent in the proactive desmopressin group. Hospital mortality (6.8% versus 6.4%,\n P<\/jats:italic>\n > 0.99), length of hospital (12.5 versus 11.7 days,\n P<\/jats:italic>\n = 0.624) and intensive care unit stays (6 versus 5.5 days,\n P<\/jats:italic>\n = 0.578), fluid overload (9.1% versus 9.5%,\n P<\/jats:italic>\n > 0.99), and worsening of hyponatremia (2.3% versus 1.5%,\n P<\/jats:italic>\n > 0.99) were similar in the two groups, but PNa was checked significantly more often in the proactive desmopressin group (20.9 versus 17.4,\n P<\/jats:italic>\n < 0.001). No cases of osmotic demyelination syndrome and no deaths from cerebral edema were identified.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n Treating severe hyponatremia with HTS and proactive desmopressin was associated with lower rates of overcorrection without significant adverse events compared with HTS without proactive desmopressin.<\/jats:p>\n <\/jats:sec>","DOI":"10.34067\/kid.0000000830","type":"journal-article","created":{"date-parts":[[2025,4,24]],"date-time":"2025-04-24T12:02:00Z","timestamp":1745496120000},"page":"1462-1471","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Plasma Sodium Correction Rates in Patients with Severe Hyponatremia Treated with Hypertonic Saline with and without Proactive Desmopressin"],"prefix":"10.34067","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1642-5022","authenticated-orcid":false,"given":"Zain","family":"AlShanableh","sequence":"first","affiliation":[{"name":"Renal-Electrolyte Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Woodall","sequence":"additional","affiliation":[{"name":"Renal-Electrolyte Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-5453-9404","authenticated-orcid":false,"given":"Michelle","family":"Chisdak","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9406-2362","authenticated-orcid":false,"given":"Jonathan G.","family":"Yabes","sequence":"additional","affiliation":[{"name":"Division of General Internal Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"},{"name":"Department of Biostatistics, University of Pittsburgh School of Public Health, Pittsburgh, Pennsylvania"},{"name":"Center for Research on Health Care Data Center, University of Pittsburgh, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9291-7761","authenticated-orcid":false,"given":"Richard H.","family":"Sterns","sequence":"additional","affiliation":[{"name":"University of Rochester School of Medicine and Dentistry, Rochester, New York"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven D.","family":"Weisbord","sequence":"additional","affiliation":[{"name":"Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"},{"name":"Renal Section, Veteran Affairs Pittsburgh Healthcare System, Pittsburgh, Pennsylvania"},{"name":"Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7109-146X","authenticated-orcid":false,"given":"Helbert","family":"Rondon-Berrios","sequence":"additional","affiliation":[{"name":"Renal-Electrolyte Division, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania"},{"name":"Renal-Electrolyte Division, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,4,24]]},"reference":[{"issue":"6","key":"B1-20251006","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1053\/j.ajkd.2021.07.020","article-title":"Hypertonic saline for hyponatremia: meeting goals and avoiding harm","volume":"79","author":"Rondon-Berrios","year":"2022","journal-title":"Am J Kidney Dis."},{"issue":"6","key":"B2-20251006","first-page":"503","article-title":"The management of symptomatic hyponatremia","volume":"10","author":"Sterns","year":"1990","journal-title":"Semin Nephrol."},{"issue":"12","key":"B3-20251006","doi-asserted-by":"crossref","first-page":"1362.e15","DOI":"10.1016\/j.amjmed.2015.04.040","article-title":"Desmopressin to prevent rapid sodium correction in severe hyponatremia: a systematic review","volume":"128","author":"MacMillan","year":"2015","journal-title":"Am J Med."},{"issue":"suppl 2","key":"B4-20251006","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1093\/ndt\/gfu040","article-title":"Clinical practice guideline on diagnosis and treatment of hyponatraemia","volume":"29","author":"Spasovski","year":"2014","journal-title":"Nephrol Dial Transplant."},{"issue":"10 suppl 1","key":"B5-20251006","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.amjmed.2013.07.006","article-title":"Diagnosis, evaluation, and treatment of hyponatremia: expert panel recommendations","volume":"126","author":"Verbalis","year":"2013","journal-title":"Am J Med."},{"key":"B6-20251006","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jcrc.2021.03.010","article-title":"Association of intranasal desmopressin therapy with overcorrection of severe hyponatremia: a retrospective, propensity score-based, single-center cohort study","volume":"64","author":"Jingushi","year":"2021","journal-title":"J Crit Care."},{"issue":"3","key":"B7-20251006","doi-asserted-by":"crossref","first-page":"317.e1","DOI":"10.1016\/j.amjmed.2017.09.048","article-title":"Outcomes in severe hyponatremia treated with and without desmopressin","volume":"131","author":"MacMillan","year":"2018","journal-title":"Am J Med."},{"issue":"6","key":"B8-20251006","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.amjms.2021.03.012","article-title":"Evaluation of desmopressin in critically ill patients with hyponatremia requiring 3% hypertonic saline","volume":"361","author":"Tran","year":"2021","journal-title":"Am J Med Sci."},{"issue":"1","key":"B9-20251006","doi-asserted-by":"crossref","first-page":"7487","DOI":"10.1038\/s41598-024-57657-z","article-title":"Safety and efficacy of proactive versus reactive administration of desmopressin in severe symptomatic hyponatremia: a randomized controlled trial","volume":"14","author":"Pakchotanon","year":"2024","journal-title":"Sci Rep."},{"issue":"5","key":"B10-20251006","doi-asserted-by":"crossref","first-page":"656","DOI":"10.7326\/0003-4819-107-5-656","article-title":"Severe symptomatic hyponatremia: treatment and outcome. A study of 64 cases","volume":"107","author":"Sterns","year":"1987","journal-title":"Ann Intern Med."},{"issue":"10","key":"B11-20251006","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1016\/j.mayocp.2015.07.014","article-title":"Sodium correction practice and clinical outcomes in profound hyponatremia","volume":"90","author":"Geoghegan","year":"2015","journal-title":"Mayo Clin Proc."},{"issue":"7","key":"B12-20251006","doi-asserted-by":"crossref","first-page":"984","DOI":"10.2215\/CJN.13061117","article-title":"Risk factors and outcomes of rapid correction of severe hyponatremia","volume":"13","author":"George","year":"2018","journal-title":"Clin J Am Soc Nephrol."},{"issue":"7","key":"B13-20251006","doi-asserted-by":"crossref","first-page":"975","DOI":"10.2215\/CJN.12251018","article-title":"Derivation and validation of a novel risk score to predict overcorrection of severe hyponatremia: the severe hyponatremia overcorrection risk (SHOR) score","volume":"14","author":"Woodfine","year":"2019","journal-title":"Clin J Am Soc Nephrol."},{"issue":"4","key":"B15-20251006","doi-asserted-by":"crossref","first-page":"EVIDe2300014","DOI":"10.1056\/EVIDe2300014","article-title":"Hyponatremia treatment guidelines - have they gone too far?","volume":"2","author":"Ayus","year":"2023","journal-title":"NEJM Evid."}],"container-title":["Kidney360"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000830","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T20:03:32Z","timestamp":1786478612000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.34067\/KID.0000000830"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,24]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.34067\/kid.0000000830","relation":{},"ISSN":["2641-7650"],"issn-type":[{"value":"2641-7650","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,24]]},"assertion":[{"value":"2025-02-10","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-04-21","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}